Pycnogenol is a natural extract derived from the bark of the French maritime pine tree, scientifically known as Pinus pinaster Aiton. This proprietary extract is rich in a variety of bioflavonoids, including procyanidins, catechin, and taxifolin, as well as phenolic acids. These compounds are known for their potent antioxidant properties, which play a significant role in the health benefits associated with Pycnogenol.

The extract is standardized to contain 70% procyanidins, making it a highly concentrated source of these beneficial compounds. Pycnogenol has been the subject of extensive research and is widely used as a dietary supplement. Its bioactive components are well-absorbed by the body, contributing to its efficacy in various health applications.

Pycnogenol is recognized for its versatility in supporting overall health. It’s used in a range of conditions due to its anti-inflammatory, antioxidant, and vasodilatory properties. These attributes make it a popular supplement for cardiovascular health, cognitive function, skin health, and more. The extract's ability to enhance blood flow, reduce oxidative stress, and support immune function underpins its wide-ranging benefits.

Pycnogenol is used for a variety of health applications, primarily due to its potent antioxidant and anti-inflammatory properties. One of its most well-researched benefits is its ability to improve cardiovascular health. Studies have shown that Pycnogenol can enhance endothelial function, which is crucial for maintaining healthy blood vessels. For instance, a study published in "Hypertension Research" found that Pycnogenol significantly augmented endothelium-dependent vasodilation in humans by increasing nitric oxide production, which helps to relax blood vessels and improve blood flow (Nishioka et al., 2007).

Another major use of Pycnogenol is in managing symptoms of chronic venous insufficiency (CVI). Research has demonstrated that Pycnogenol can significantly reduce leg swelling, pain, and heaviness associated with CVI. A study published in "Fitoterapia" found that supplementation with Pycnogenol led to a significant reduction in subcutaneous edema as well as heaviness and pain in the legs of CVI patients (Arcangeli, 2000). These findings suggest that Pycnogenol can be an effective adjunct to compression therapy for improving venous health.

Pycnogenol is also explored for its potential benefits in managing blood glucose levels and improving symptoms in type 2 diabetes patients. A systematic review and meta-analysis published in "Pharmacological Research" indicated that Pycnogenol supplementation significantly reduced fasting blood glucose and glycated hemoglobin (HbA1c) levels, suggesting it may play a role in preventing cardiometabolic diseases (Malekahmadi et al., 2019). Moreover, Pycnogenol has shown promise in reducing symptoms of osteoarthritis. A study in "Phytotherapy Research" reported that patients taking Pycnogenol experienced significant reductions in pain and stiffness, along with improved physical function (Belcaro et al., 2008).

In summary, Pycnogenol is used for cardiovascular health, chronic venous insufficiency, blood glucose management, and osteoarthritis, among other conditions. The scientific literature supports its efficacy in these areas, highlighting its potential as a versatile and beneficial supplement.

Pycnogenol works through multiple mechanisms primarily attributed to its rich composition of bioflavonoids and phenolic acids. One of its key mechanisms is its potent antioxidant activity. Pycnogenol contains compounds like procyanidins, catechin, and taxifolin, which neutralize free radicals and reduce oxidative stress in the body. This action helps protect cells and tissues from damage, which is particularly beneficial in preventing and managing conditions linked to oxidative stress, such as cardiovascular diseases and neurodegenerative disorders (Packer et al., 1999).

Another significant mechanism of Pycnogenol is its anti-inflammatory properties. Pycnogenol inhibits the activity of pro-inflammatory enzymes like cyclooxygenase (COX) and lipoxygenase, and reduces the production of inflammatory cytokines such as interleukins and tumor necrosis factor-alpha (TNF-α). This anti-inflammatory effect is particularly beneficial in managing conditions like osteoarthritis and chronic venous insufficiency, where inflammation plays a critical role. For instance, a study published in "Redox Report" found that Pycnogenol significantly decreased C-reactive protein (CRP) levels, a marker of inflammation, in patients with osteoarthritis (Belcaro et al., 2008).

Pycnogenol also enhances endothelial function, which is crucial for maintaining healthy blood vessels. It does this by increasing the production of nitric oxide (NO), a molecule that helps relax blood vessels, improve blood flow, and reduce blood pressure. A study in "Hypertension Research" demonstrated that Pycnogenol supplementation significantly augmented endothelium-dependent vasodilation by increasing NO production (Nishioka et al., 2007). This vasodilatory effect is beneficial in conditions like hypertension and chronic venous insufficiency, where improved blood flow can alleviate symptoms.

Additionally, Pycnogenol has been shown to modulate blood glucose levels by enhancing insulin sensitivity and improving glucose uptake in cells. This is particularly beneficial for individuals with type 2 diabetes. A systematic review and meta-analysis in "Pharmacological Research" reported that Pycnogenol supplementation significantly reduced fasting blood glucose and HbA1c levels, indicating improved glycemic control (Malekahmadi et al., 2019).

In summary, Pycnogenol works through antioxidant, anti-inflammatory, and vasodilatory mechanisms, along with improving endothelial function and blood glucose control. These multifaceted actions contribute to its wide range of health benefits.

Pycnogenol is used to address various health concerns in both men and women, but some of its applications are particularly tailored to the unique physiological needs of each gender.

In men's health, Pycnogenol is often used to support cardiovascular health and manage erectile dysfunction. Its ability to enhance nitric oxide production and improve blood flow is particularly beneficial in these areas. A study published in "Hypertension Research" found that Pycnogenol significantly improved endothelium-dependent vasodilation, which can help manage conditions like hypertension and improve overall cardiovascular function (Nishioka et al., 2007). Additionally, the enhancement of nitric oxide production has been linked to improved erectile function, making Pycnogenol a valuable supplement for men facing erectile dysfunction.

For women, Pycnogenol is frequently used to alleviate symptoms associated with menstrual disorders and menopause. Its anti-inflammatory and antioxidant properties can help reduce menstrual pain and discomfort. A study published in the "Journal of Reproductive Medicine" found that women who took Pycnogenol experienced significant reductions in menstrual pain and symptom severity compared to those who took a placebo. Furthermore, Pycnogenol has been shown to improve skin elasticity and hydration, which can be particularly beneficial for women experiencing skin changes due to hormonal fluctuations during menopause (Ryan et al., 2008).

Pycnogenol is also used to manage symptoms of chronic venous insufficiency (CVI) in both men and women, but it may be especially beneficial for women who are at higher risk for this condition due to factors like pregnancy and hormonal changes. A study in "Phytomedicine" found that Pycnogenol significantly reduced leg swelling, pain, and heaviness in individuals with CVI (Cesarone et al., 2010). Given that women are more likely to develop CVI, Pycnogenol can be an important supplement for maintaining venous health.

In summary, while Pycnogenol offers general health benefits for both men and women, its specific applications can vary. In men, it is often used to support cardiovascular health and manage erectile dysfunction, while in women, it is frequently used to alleviate menstrual and menopausal symptoms and improve skin health. Its use in managing chronic venous insufficiency is beneficial for both genders, with particular importance for women.

The appropriate dosage of Pycnogenol can vary depending on the specific health condition being addressed, the individual's health status, and the formulation of the supplement. Generally, studies have used a range of dosages, typically between 50 mg to 200 mg per day, with some conditions requiring higher amounts for optimal efficacy.

For cardiovascular health and improving endothelial function, a common dosage is around 100 mg to 200 mg per day. For instance, a study published in "Hypertension Research" demonstrated significant improvements in endothelium-dependent vasodilation with a daily dosage of 180 mg of Pycnogenol (Nishioka et al., 2007). This dosage has been effective in enhancing blood flow and supporting overall cardiovascular health.

In the management of chronic venous insufficiency (CVI), studies have frequently used a dosage of 150 mg per day. A study in "Phytomedicine" found that this dosage significantly reduced leg swelling, pain, and heaviness in CVI patients over an 8-week period (Cesarone et al., 2010). Similarly, for reducing symptoms of osteoarthritis, a daily dosage of 100 mg to 150 mg has been shown to be effective. Research published in "Phytotherapy Research" reported that 100 mg per day of Pycnogenol significantly decreased pain and improved physical function in osteoarthritis patients (Belcaro et al., 2008).

For blood glucose management in type 2 diabetes, dosages of 100 mg to 200 mg per day have been used. A systematic review and meta-analysis in "Pharmacological Research" indicated that these dosages significantly reduced fasting blood glucose and HbA1c levels (Malekahmadi et al., 2019).

When it comes to alleviating menstrual pain and menopausal symptoms, dosages can range from 60 mg to 200 mg per day, depending on the severity of symptoms. For example, a study found that 60 mg per day was effective in reducing menstrual pain (Ryan et al., 2008).

It is important to note that while these dosages are supported by research, individual responses can vary. Therefore, it is advisable to start with a lower dose and gradually increase it as needed, under the guidance of a healthcare professional. Always follow the dosage instructions provided on the supplement label or those recommended by a healthcare provider to ensure safe and effective use.

Pycnogenol is generally well-tolerated by most individuals, but like any supplement, it can cause side effects in some people. The most commonly reported side effects are mild and transient, typically including gastrointestinal issues such as stomach upset, nausea, and diarrhea. These symptoms are often short-lived and may diminish as the body adjusts to the supplement.

In some cases, individuals may experience headaches, dizziness, or mouth ulcers. These side effects are relatively rare and usually not severe. A study published in "Phytotherapy Research" noted that Pycnogenol was well-tolerated by participants, with only mild and transient side effects reported (Belcaro et al., 2008).

Allergic reactions to Pycnogenol are uncommon but can occur. Symptoms of an allergic reaction might include itching, rash, hives, or swelling, particularly if you have a known allergy to pine tree products. If any allergic reactions are observed, it is crucial to discontinue use immediately and seek medical attention.

It is worth mentioning that while Pycnogenol has been shown to be safe for most people, long-term safety data is still limited. Therefore, it is essential to use the supplement as directed and consult a healthcare professional before starting Pycnogenol, especially if you have any pre-existing medical conditions or are taking other medications.

In summary, while Pycnogenol is generally safe and well-tolerated, potential side effects can include mild gastrointestinal issues, headaches, dizziness, and, rarely, allergic reactions. Always consult a healthcare provider before beginning any new supplement regimen.

While Pycnogenol is generally considered safe for most people, certain individuals should exercise caution or avoid using it altogether. Pregnant and breastfeeding women should be particularly cautious. There is limited research on the safety of Pycnogenol during pregnancy and lactation, so it is advisable to avoid its use unless specifically recommended by a healthcare provider.

Individuals with autoimmune diseases, such as lupus, multiple sclerosis, or rheumatoid arthritis, should also be cautious. Pycnogenol's immune-modulating effects may potentially exacerbate these conditions. Consulting a healthcare provider before starting Pycnogenol is essential for individuals with autoimmune disorders to ensure it does not interfere with their condition or treatment.

People who are scheduled for surgery or have bleeding disorders should avoid Pycnogenol. The supplement can have antiplatelet effects, which might increase the risk of bleeding. It is recommended to discontinue Pycnogenol at least two weeks before any surgical procedure to minimize potential bleeding risks.

Individuals taking anticoagulant or antiplatelet medications, such as warfarin, aspirin, or clopidogrel, should be cautious as well. Pycnogenol may enhance the effects of these medications, increasing the risk of bleeding. It is crucial to discuss the use of Pycnogenol with a healthcare provider to ensure it does not interact negatively with any prescribed medications.

Lastly, people with known allergies to pine bark or pine tree products should avoid Pycnogenol to prevent allergic reactions. Symptoms of an allergic reaction can include itching, rash, hives, and swelling, and immediate discontinuation and medical attention are advised if these occur.

In summary, pregnant and breastfeeding women, individuals with autoimmune diseases, those scheduled for surgery or with bleeding disorders, people taking anticoagulant or antiplatelet medications, and individuals with known pine allergies should avoid or exercise caution with Pycnogenol. Consulting a healthcare professional before starting Pycnogenol is advisable for these groups to ensure safety and avoid potential complications.

Yes, Pycnogenol supplements can interact with certain medications, and it is important to be aware of these potential interactions to ensure safety and effectiveness. One of the most notable interactions is with anticoagulant and antiplatelet medications. Pycnogenol has been shown to have antiplatelet effects, which can increase the risk of bleeding when taken alongside blood-thinning medications such as warfarin, aspirin, clopidogrel, and other similar drugs. If you are taking any of these medications, it is crucial to consult your healthcare provider before starting Pycnogenol to avoid any adverse effects.

Pycnogenol may also interact with medications used to manage blood pressure. While Pycnogenol has been shown to have beneficial effects on blood pressure by improving endothelial function and promoting vasodilation, it could potentially enhance the effects of antihypertensive medications. This interaction might lead to an excessive drop in blood pressure, causing symptoms like dizziness, lightheadedness, or fainting. Therefore, individuals on blood pressure medications should closely monitor their blood pressure and consult their healthcare provider before incorporating Pycnogenol into their regimen.

Additionally, Pycnogenol can interact with medications that affect the immune system. Since Pycnogenol has immune-modulating properties, it may influence the efficacy of immunosuppressive drugs used in conditions such as autoimmune diseases or post-organ transplantation. This interaction could potentially reduce the effectiveness of these medications or exacerbate underlying conditions. It is essential to consult a healthcare provider if you are taking immunosuppressive drugs and considering Pycnogenol supplementation.

Furthermore, Pycnogenol may have interactions with medications metabolized by the liver. Some studies suggest that Pycnogenol can influence liver enzyme activity, which might affect the metabolism and clearance of certain drugs. This interaction could alter the concentration of medications in the bloodstream, leading to either reduced efficacy or increased risk of side effects. If you are taking medications that are extensively metabolized by the liver, it is advisable to discuss the use of Pycnogenol with your healthcare provider.

In summary, Pycnogenol supplements can interact with anticoagulant and antiplatelet medications, antihypertensive drugs, immunosuppressive medications, and drugs metabolized by the liver. Consulting a healthcare professional before starting Pycnogenol is essential to avoid potential interactions and ensure safe and effective use.

The best sources of Pycnogenol come from supplements that are derived from the bark of the French maritime pine tree (Pinus pinaster Aiton), specifically from trees grown in the coastal regions of southwest France. This proprietary extract is standardized to contain 70% procyanidins, which are the active compounds responsible for its health benefits. When choosing a Pycnogenol supplement, it is important to ensure that it is made from this specific source to guarantee its efficacy and safety.

Dietary supplements containing Pycnogenol are widely available in various forms, including capsules, tablets, and powders. Reputable brands often provide detailed information about the source and standardization of their Pycnogenol extract, which can help consumers make informed choices. Some well-known brands that offer high-quality Pycnogenol supplements include Horphag Research, the company that holds the trademark for Pycnogenol, as well as other reputable supplement manufacturers that source their Pycnogenol from Horphag.

When selecting a Pycnogenol supplement, it is important to look for third-party testing and certification to ensure product quality and purity. Certifications from organizations such as the United States Pharmacopeia (USP), NSF International, or ConsumerLab can provide additional assurance that the supplement contains the stated amount of active ingredients and is free from contaminants.

In addition to supplements, Pycnogenol can also be found in some functional foods and beverages that are fortified with the extract. These products may include health drinks, nutrition bars, and other fortified food items. However, the concentration of Pycnogenol in these products may be lower compared to dietary supplements, so it is important to check the label for the specific amount of Pycnogenol provided.

In summary, the best sources of Pycnogenol are dietary supplements derived from the bark of the French maritime pine tree, specifically standardized to contain 70% procyanidins. Reputable brands that provide third-party testing and certification are recommended to ensure product quality and purity. Additionally, functional foods and beverages fortified with Pycnogenol can be an alternative source, though the concentration may be lower than in dedicated supplements.

Pycnogenol is available in several forms, making it convenient for different preferences and needs. The most common forms include capsules, tablets, powders, and topical applications. Each form has its specific uses and benefits, allowing for versatility in supplementation.

Capsules and Tablets: These are the most popular forms of Pycnogenol supplements. They are easy to take and provide a standardized dose, ensuring consistency in the amount of active ingredients consumed. Capsules and tablets are widely available and can be found in various dosages, typically ranging from 50 mg to 200 mg per serving. They are ideal for individuals who prefer a straightforward and convenient method of supplementation.

Powders: Pycnogenol powder is another option, offering flexibility in how it can be consumed. The powder can be mixed with water, juice, smoothies, or other beverages, making it a versatile choice for those who prefer not to take capsules or tablets. This form also allows for customizable dosing, which can be particularly useful for individuals who need to adjust their intake based on specific health needs or recommendations from a healthcare provider.

Topical Applications: Pycnogenol is also available in topical forms, such as creams, gels, and serums, which are applied directly to the skin. These products are often used for their antioxidant and anti-inflammatory properties to improve skin health. Topical Pycnogenol can help reduce the appearance of fine lines and wrinkles, improve skin elasticity, and promote overall skin hydration. It is a popular choice for individuals looking to enhance their skincare routine with a natural, antioxidant-rich ingredient.

Functional Foods and Beverages: In addition to supplements, Pycnogenol can be found in some functional foods and beverages that are fortified with the extract. These products may include health drinks, nutrition bars, and other fortified food items. While the concentration of Pycnogenol in these products may be lower compared to dietary supplements, they can still provide a convenient way to incorporate the benefits of Pycnogenol into a daily diet.

In summary, Pycnogenol is available in various forms, including capsules, tablets, powders, topical applications, and functional foods and beverages. Each form offers unique benefits and can be chosen based on individual preferences and health needs. Whether you prefer the convenience of capsules, the versatility of powders, or the skincare benefits of topical applications, there is a Pycnogenol product to suit your requirements.

The efficacy of Pycnogenol is largely attributed to its rich composition of bioactive sub-compounds, primarily procyanidins, catechin, taxifolin, and phenolic acids. These compounds work synergistically to provide the wide range of health benefits associated with Pycnogenol.

Procyanidins: Procyanidins are a group of flavonoids that make up a significant portion of Pycnogenol's composition. These compounds are known for their potent antioxidant properties, which help neutralize free radicals and reduce oxidative stress in the body. Procyanidins also have anti-inflammatory effects, contributing to the management of conditions such as osteoarthritis and chronic venous insufficiency. A study published in "Free Radical Biology & Medicine" highlighted the antioxidant activity of procyanidins and their role in protecting cells from oxidative damage (Packer et al., 1999).

Catechin: Catechin is another flavonoid present in Pycnogenol, known for its strong antioxidant and anti-inflammatory properties. It helps in scavenging free radicals and protecting cells from oxidative stress. Catechin has been shown to improve cardiovascular health by enhancing endothelial function and promoting vasodilation. Its presence in Pycnogenol contributes to the supplement's overall efficacy in managing cardiovascular conditions and improving blood flow.

Taxifolin: Taxifolin, also known as dihydroquercetin, is a flavonoid with notable antioxidant and anti-inflammatory effects. It helps inhibit the production of pro-inflammatory cytokines and enzymes, thereby reducing inflammation. Taxifolin also supports cardiovascular health by enhancing nitric oxide production, which aids in vasodilation and improved blood flow. The presence of taxifolin in Pycnogenol further enhances its ability to manage conditions related to inflammation and poor circulation.

Phenolic Acids: Pycnogenol contains several phenolic acids, such as ferulic acid and caffeic acid, which contribute to its antioxidant and anti-inflammatory properties. These phenolic acids help protect cells from oxidative damage and reduce the risk of chronic diseases. They also play a role in modulating immune responses and improving overall health.

The synergy between these sub-compounds is crucial for the effectiveness of Pycnogenol. While each compound has its unique benefits, their combined action enhances the overall therapeutic potential of the supplement. This synergistic effect is one of the reasons why Pycnogenol is effective in managing a wide range of health conditions, from cardiovascular health to skin care and inflammation.

In summary, the critical sub-compounds of Pycnogenol include procyanidins, catechin, taxifolin, and phenolic acids. These bioactive components work synergistically to provide the antioxidant, anti-inflammatory, and vasodilatory effects that underpin the wide range of health benefits associated with Pycnogenol.

Pycnogenol is also known by several other names and terms, which are often used interchangeably in scientific literature and commercial products. Understanding these various terms can help in identifying the supplement and its active components.

Common Names and Misspellings:

1. French Maritime Pine Bark Extract: This is a descriptive name that emphasizes the source of Pycnogenol.
2. Pine Bark Extract: A more generic term that includes extracts from various species of pine trees, but often used to refer to Pycnogenol.
3. Pinus Pinaster Extract: Refers to the botanical name of the French maritime pine tree from which Pycnogenol is derived.
4. Procyanidolic Oligomers (PCOs): A term sometimes used to describe the group of flavonoids, specifically procyanidins, which are the primary active compounds in Pycnogenol.
5. Pycnogenol®: The registered trademark name for the specific extract of French maritime pine bark produced by Horphag Research.

Common Misspellings:

1. Pycogenol
2. Piknogenol
3. Pyncogenol
4. Piknoginol

Abbreviations:

1. PYC: A common abbreviation used in scientific studies and literature to refer to Pycnogenol.

Chemical Compounds and Ingredients:

1. Procyanidins: These are the primary active compounds in Pycnogenol, known for their antioxidant and anti-inflammatory properties.
2. Catechin: A type of flavonoid found in Pycnogenol, contributing to its health benefits.
3. Taxifolin (Dihydroquercetin): Another flavonoid present in Pycnogenol, known for its antioxidant effects.
4. Phenolic Acids: Including ferulic acid and caffeic acid, which add to the antioxidant and anti-inflammatory properties of Pycnogenol.

Related Terms:

1. Oligomeric Proanthocyanidins (OPCs): A broader category of compounds that includes procyanidins, which are a significant component of Pycnogenol.
2. Flavonoids: A class of polyphenolic compounds that includes procyanidins, catechin, and taxifolin, all of which are found in Pycnogenol.

In summary, Pycnogenol is also known as French Maritime Pine Bark Extract, Pine Bark Extract, and Pinus Pinaster Extract. Common misspellings include Pycogenol, Piknogenol, Pyncogenol, and Piknoginol. Abbreviations like PYC are frequently used in scientific literature. The critical chemical compounds in Pycnogenol include procyanidins, catechin, taxifolin, and phenolic acids, which contribute to its wide range of health benefits.

When selecting a Pycnogenol supplement, it is essential to carefully examine the label to ensure product quality and efficacy. Here are some key factors to consider:

1. Standardization and Source:
   • Ensure that the supplement is derived from French maritime pine bark (Pinus pinaster Aiton). The label should specify this source to guarantee the authenticity of the Pycnogenol extract.
   • Look for standardization to contain 70% procyanidins. This standardization ensures that the supplement contains a consistent and effective amount of the active compounds responsible for its health benefits.
2. Dosage:
   • Check the dosage per serving to ensure it aligns with the amounts used in clinical studies. Common dosages range from 50 mg to 200 mg per day, depending on the specific health condition being addressed.
3. Third-Party Testing and Certification:
   • Look for third-party testing and certification logos on the label. Reputable certifications such as United States Pharmacopeia (USP), NSF International, or ConsumerLab indicate that the product has been independently tested for quality, purity, and potency.
   • These certifications ensure that the supplement contains the stated amount of active ingredients and is free from contaminants such as heavy metals, pesticides, and other harmful substances.
4. Ingredient List:
   • Review the ingredient list to ensure there are no unnecessary additives, fillers, or artificial ingredients. A high-quality Pycnogenol supplement should contain minimal additional ingredients beyond those necessary for the capsule or tablet formulation.
   • Check for potential allergens if you have any known allergies. Some supplements may contain ingredients like soy, gluten, or other allergens.
5. Manufacturer Information:
   • Ensure that the label provides clear information about the manufacturer, including contact details and the location of production. Reputable manufacturers are transparent about their sourcing and manufacturing processes.
   • Look for manufacturers that adhere to Good Manufacturing Practices (GMP), which ensure that the supplement is produced under strict quality control standards.
6. Expiration Date and Storage Instructions:
   • Check the expiration date to ensure the supplement is within its shelf life. Using a product past its expiration date may result in reduced potency and effectiveness.
   • Follow any storage instructions provided on the label to maintain the supplement's quality and efficacy. Proper storage conditions, such as keeping the product in a cool, dry place, can help preserve its active ingredients.
7. Usage Instructions:
   • Read the usage instructions carefully to ensure you are taking the supplement correctly. This includes information on the recommended dosage, timing, and whether it should be taken with or without food.

In summary, to ensure the quality of a Pycnogenol supplement, look for standardization to 70% procyanidins, third-party testing and certification, a clear ingredient list, reputable manufacturer information, an expiration date, and proper usage instructions. These factors will help you select a high-quality supplement that provides the intended health benefits.

The information provided on this website, including any text, images, or other material contained within, is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. This page was created by the SuppCo editiorial team, with AI summarization tools, including data from but not limited to following studies:

1. P. Arcangeli (2000). Pycnogenol in chronic venous insufficiency.. Fitoterapia, 71 3,
   236-44 . Link: 10.1016/S0367-326X(99)00164-1
2. K. Nishioka, T. Hidaka, Shuji Nakamura, Takashi Umemura, Daisuke Jitsuiki, J. Soga, Chikara Goto, K. Chayama, M. Yoshizumi, Y. Higashi (2007). Pycnogenol®, French Maritime Pine Bark Extract, Augments Endothelium-Dependent Vasodilation in Humans. Hypertension Research, 30, 775-780. Link: 10.1291/hypres.30.775
3. F. Fogacci, G. Tocci, A. Sahebkar, V. Presta, M. Banach, A. Cicero (2019). Effect of Pycnogenol on Blood Pressure: Findings From a PRISMA Compliant Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled, Clinical Studies. Angiology, 71, 217 - 225. Link: 10.1177/0003319719889428
4. Zheng Zhang, X. Tong, Yu-Lu Wei, Lin Zhao, Jia-Ying Xu, L. Qin (2018). Effect of Pycnogenol Supplementation on Blood Pressure: A Systematic Review and Meta-analysis. Iranian Journal of Public Health, 47, 779 - 787. Link:
5. A. Hadi, M. Pourmasoumi, H. Mohammadi, Aftab Javaheri, M. Rouhani (2018). The impact of pycnogenol supplementation on plasma lipids in humans: A systematic review and meta‐analysis of clinical trials. Phytotherapy Research, 33, 276 - 287. Link: 10.1002/ptr.6234
6. M. Pourmasoumi, A. Hadi, H. Mohammadi, M. Rouhani (2020). Effect of pycnogenol supplementation on blood pressure: A systematic review and meta‐analysis of clinical trials. Phytotherapy Research, 34, 67 - 76. Link: 10.1002/ptr.6515
7. E. Kráľová, S. Jankyova, P. Mučaji, Eva Gresakova, T. Stankovičová (2015). Pycnogenol® and its fractions influence the function of isolated heart in rats with experimental diabetes mellitus.. Pathology, research and practice, 211 2,
   156-61 . Link: 10.1016/j.prp.2014.11.011
8. F. Enseleit, I. Sudano, D. Périat, S. Winnik, M. Wolfrum, A. Flammer, G. Fröhlich, P. Kaiser, A. Hirt, S. Haile, Nazmi Krasniqi, C. Matter, Klaus Uhlenhut, P. Högger, M. Neidhart, T. Lüscher, F. Ruschitzka, G. Noll (2012). Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.. European heart journal, 33 13,
   1589-97 . Link: 10.1093/eurheartj/ehr482
9. Mahsa Malekahmadi, Safieh Firouzi, Reza Daryabeygi-Khotbehsara, Sheikh Mohammed Shariful Islam, A. Norouzy, Omid Moradi Moghaddam, Sepideh Soltani (2019). Effects of Pycnogenol on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Pharmacological research, ,
   104472 . Link: 10.1016/j.phrs.2019.104472
10. G. Belcaro, U. Cornelli, M. Cesarone, C. Scipione, V. Scipione, Shu Hu, B. Feragalli, M. Corsi, David Cox, R. Cotellese, M. Hosoi (2021). Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19).. Minerva medica, , . Link: 10.23736/S0026-4806.21.07650-3
11. Zhao Liu, Bo Han, Xing Chen, Qiao-Feng Wu, Li-jun Wang, Gang Li (2016). Pycnogenol Ameliorates Asthmatic Airway Inflammation and Inhibits the Function of Goblet Cells.. DNA and cell biology, 35 11,
    730-739 . Link: 10.1089/DNA.2016.3264
12. A. Schoonees, J. Visser, A. Musekiwa, J. Volmink (2012). Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders.. The Cochrane database of systematic reviews, 4,
    CD008294 . Link: 10.1002/14651858.CD008294.pub4
13. G. Belcaro, R. Luzzi, P. Cesinaro Di Rocco, M. Cesarone, M. Dugall, B. Feragalli, B. Errichi, E. Ippolito, M. Grossi, M. Hosoi, S. Errichi, U. Cornelli, A. Ledda, G. Gizzi (2011). Pycnogenol® improvements in asthma management.. Panminerva medica, 53 3 Suppl 1,
    57-64 . Link:
14. S. Hosseini, S. Pishnamazi, S. Sadrzadeh, F. Farid, R. Farid, R. Watson (2001). Pycnogenol((R)) in the Management of Asthma.. Journal of medicinal food, 4 4,
    201-209 . Link: 10.1089/10966200152744472
15. I. Shin, Na-Rae Shin, Chan-Mi Jeon, Ju-Mi Hong, O. Kwon, Jong-Choon Kim, Sei-Ryang Oh, Kyu-Woung Hahn, K. Ahn (2013). Inhibitory effects of Pycnogenol® (French maritime pine bark extract) on airway inflammation in ovalbumin-induced allergic asthma.. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 62,
    681-6 . Link: 10.1016/j.fct.2013.09.032
16. R. Watson, P. Rohdewald, Graciela E. Silva (2007). Asthma risk factors in Desert Southwest of USA: Role of nutritional supplement, Pycnogenol® in therapy. Journal of Nutritional & Environmental Medicine, 16, 33-38. Link: 10.1080/13590840701324855
17. R. Farid, S. Hosseini, R. Pishnamaz, R. Watson (2003). Pycnogenol® in the Management of Asthma. The Journal of Allergy and Clinical Immunology, 111, . Link: 10.1016/S0091-6749(03)80440-2
18. B. Lau, Sharon K Riesen, K. P. Truong, E. W. Lau, P. Rohdewald, Ray A Barreta (2004). Pycnogenol® as an Adjunct in the Management of Childhood Asthma. Journal of Asthma, 41, 825 - 832. Link: 10.1081/JAS-200038433
19. S. Ross (2016). Allergic Rhinitis: A Proprietary Extract of Pinus pinaster Aiton (Pycnogenol) Is Found to Improve the Symptoms Associated With Allergic Rhinitis. Holistic Nursing Practice, 30, 301–304. Link: 10.1097/HNP.0000000000000170
20. Ximing Liu, Junping Wei, F. Tan, Shengmin Zhou, G. Würthwein, P. Rohdewald (2004). Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II.. Life sciences, 75 21,
    2505-13 . Link: 10.1016/J.LFS.2003.10.043
21. Kehkashan Parveen, Mohd Rashid Khan, M. Mujeeb, W. Siddiqui (2010). Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats.. Chemico-biological interactions, 186 2,
    219-27 . Link: 10.1016/j.cbi.2010.04.023
22. Hee-Hyun Lee, Kui-Jin Kim, O. Lee, Boo-Yong Lee (2010). Effect of pycnogenol® on glucose transport in mature 3T3‐L1 Adipocytes. Phytotherapy Research, 24, . Link: 10.1002/ptr.3193
23. Ximing Liu, Ha-Jun Zhou, P. Rohdewald (2004). French maritime pine bark extract Pycnogenol dose-dependently lowers glucose in type 2 diabetic patients.. Diabetes care, 27 3,
    839 . Link: 10.2337/DIACARE.27.3.839
24. Kehkashan Parveen, Tauheed Ishrat, S. Malik, M. A. Kausar, W. Siddiqui (2012). Modulatory effects of Pycnogenol® in a rat model of insulin-dependent diabetes mellitus: biochemical, histological, and immunohistochemical evidences. Protoplasma, 250, 347 - 360. Link: 10.1007/s00709-012-0418-2
25. S. Zibadi, P. Rohdewald, Danna Park, Ronald Ross Watson (2008). Reduction of Cardiovascular Risk Factors in Subjects with Type 2 Diabetes by Pycnogenol® Supplementation. The FASEB Journal, 22, . Link: 10.1016/j.nutres.2008.03.003
26. O. P. Gulati (2015). Pycnogenol® in Metabolic Syndrome and Related Disorders. Phytotherapy Research, 29, 949 - 968. Link: 10.1002/ptr.5341
27. Mahsa Malekahmadi, Safieh Firouzi, Reza Daryabeygi-Khotbehsara, Sheikh Mohammed Shariful Islam, A. Norouzy, Omid Moradi Moghaddam, Sepideh Soltani (2019). Effects of Pycnogenol on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Pharmacological research, ,
    104472 . Link: 10.1016/j.phrs.2019.104472
28. S. Jankyova, P. Kučera, Z. Goldenberg, D. Yaghi, J. Navarová, Z. Kyselova, S. Stolc, J. Klimas, E. Račanská, S. Mátyás (2009). Pycnogenol® efficiency on glycaemia, motor nerve conduction velocity and markers of oxidative stress in mild type diabetes in rats. Phytotherapy Research, 23, . Link: 10.1002/ptr.2776
29. O. P. Gulati (2005). The nutraceutical Pycnogenol: its role in cardiovascular health and blood glucose control. Biomedical Reviews, 16, 49-57. Link: 10.14748/BMR.V16.94
30. S. Hosseini, Jeongmin Lee, R. T. Sepúlveda, P. Rohdewald, R. Watson (2001). A randomized, double-blind, placebo-controlled, prospective, 16 week crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patients. Nutrition Research, 21, 1251-1260. Link: 10.1016/S0271-5317(01)00342-6
31. M. Pourmasoumi, A. Hadi, H. Mohammadi, M. Rouhani (2020). Effect of pycnogenol supplementation on blood pressure: A systematic review and meta‐analysis of clinical trials. Phytotherapy Research, 34, 67 - 76. Link: 10.1002/ptr.6515
32. F. Fogacci, G. Tocci, A. Sahebkar, V. Presta, M. Banach, A. Cicero (2019). Effect of Pycnogenol on Blood Pressure: Findings From a PRISMA Compliant Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled, Clinical Studies. Angiology, 71, 217 - 225. Link: 10.1177/0003319719889428
33. Zheng Zhang, X. Tong, Yu-Lu Wei, Lin Zhao, Jia-Ying Xu, L. Qin (2018). Effect of Pycnogenol Supplementation on Blood Pressure: A Systematic Review and Meta-analysis. Iranian Journal of Public Health, 47, 779 - 787. Link:
34. L. P. van der Zwan, P. Scheffer, T. Teerlink (2010). Reduction of myeloperoxidase activity by melatonin and pycnogenol may contribute to their blood pressure lowering effect.. Hypertension, 56 3,
    e34; author reply e35 . Link: 10.1161/HYPERTENSIONAHA.110.158170
35. S. Zibadi, P. Rohdewald, Danna Park, Ronald Ross Watson (2008). Reduction of Cardiovascular Risk Factors in Subjects with Type 2 Diabetes by Pycnogenol® Supplementation. The FASEB Journal, 22, . Link: 10.1016/j.nutres.2008.03.003
36. Mahsa Malekahmadi, Safieh Firouzi, Reza Daryabeygi-Khotbehsara, Sheikh Mohammed Shariful Islam, A. Norouzy, Omid Moradi Moghaddam, Sepideh Soltani (2019). Effects of Pycnogenol on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Pharmacological research, ,
    104472 . Link: 10.1016/j.phrs.2019.104472
37. Ximing Liu, Junping Wei, F. Tan, Shengmin Zhou, G. Würthwein, P. Rohdewald (2004). Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients.. Life sciences, 74 7,
    855-62 . Link: 10.1016/J.LFS.2003.07.037
38. M. Pütter, K. Grotemeyer, G. Würthwein, M. Araghi-Niknam, R. Watson, S. Hosseini, P. Rohdewald (1999). Inhibition of smoking-induced platelet aggregation by aspirin and pycnogenol.. Thrombosis research, 95 4,
    155-61 . Link: 10.1016/S0049-3848(99)00030-4
39. Cesarone Mr, G. Belcaro, Peter Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, E. Ippolito, F. Fano, M. Dugall, M. Cacchio, A. Renzo, M. Hosoi, S. Stuard, M. Corsi (2010). Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 17 11,
    835-9 . Link: 10.1016/j.phymed.2010.04.009
40. P. Rohdewald (2015). A tannic extract (Pycnogenol®) for oral and topic treatment of CVI and haemorrhoids. Phlebologie, 44, 334-338. Link:
41. G. Belcaro (2015). A Clinical Comparison of Pycnogenol, Antistax, and Stocking in Chronic Venous Insufficiency. International Journal of Angiology, 24, 268 - 274. Link: 10.1055/s-0035-1556060
42. M. Cesarone, G. Belcaro, G. Agus, E. Ippolito, M. Dugall, M. Hosoi, M. Corsi, R. Cotellese, B. Feragalli, C. Scipione, V. Scipione, C. Maione (2019). Chronic venous insufficiency and venous microangiopathy: management with compression and Pycnogenol®.. Minerva cardioangiologica, 67 4,
    280-287 . Link: 10.23736/S0026-4725.19.04948-X
43. G. Belcaro, M. Cesarone, B. Errichi, A. Ledda, A. Di Renzo, S. Stuard, M. Dugall, L. Pellegrini, P. Rohdewald, E. Ippolito, A. Ricci, M. Cacchio, I. Ruffini, F. Fano, M. Hosoi (2005). Venous Ulcers: Microcirculatory Improvement and Faster Healing with Local Use of Pycnogenol®. Angiology, 56, 699 - 705. Link: 10.1177/000331970505600607
44. Cesarone Mr, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, M. Dugall, G. Acerbi, M. Cacchio, A. Renzo, M. Hosoi, S. Stuard, M. Corsi (2006). Comparison of Pycnogenol® and Daflon® in Treating Chronic Venous Insufficiency: A Prospective, Controlled Study. Clinical and Applied Thrombosis/Hemostasis, 12, 205 - 212. Link: 10.1177/107602960601200209
45. O. P. Gulati (2014). Pycnogenol® in Chronic Venous Insufficiency and Related Venous Disorders. Phytotherapy Research, 28, . Link: 10.1002/ptr.5019
46. Cesarone Mr, G. Belcaro, Peter Rohdewald, L. Pellegrini, Andrea Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, M. Dugall, G. Acerbi, M. Cacchio, A. D. Renzo, M. Hosoi, S. Stuard, M. Corsi (2006). Rapid Relief of Signs/Symptoms in Chronic Venous Microangiopathy With Pycnogenol®: A Prospective, Controlled Study. Angiology, 57, 569 - 576. Link: 10.1177/0003319706291392
47. P. Arcangeli (2000). Pycnogenol in chronic venous insufficiency.. Fitoterapia, 71 3,
    236-44 . Link: 10.1016/S0367-326X(99)00164-1
48. C. Petrassi, A. Mastromarino, C. Spartera (2000). PYCNOGENOL in chronic venous insufficiency.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 7 5,
    383-8 . Link: 10.1016/S0944-7113(00)80059-8
49. N. Mitsutomi, Chitose Akashi, J. Odagiri, Yasuo Matsumura (1999). Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells.. European journal of pharmacology, 364 1,
    65-73 . Link: 10.1016/S0014-2999(98)00806-1
50. Ximing Liu, Junping Wei, F. Tan, Shengmin Zhou, G. Würthwein, P. Rohdewald (2004). Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II.. Life sciences, 75 21,
    2505-13 . Link: 10.1016/J.LFS.2003.10.043
51. K. Nishioka, T. Hidaka, Shuji Nakamura, Takashi Umemura, Daisuke Jitsuiki, J. Soga, Chikara Goto, K. Chayama, M. Yoshizumi, Y. Higashi (2007). Pycnogenol®, French Maritime Pine Bark Extract, Augments Endothelium-Dependent Vasodilation in Humans. Hypertension Research, 30, 775-780. Link: 10.1291/hypres.30.775
52. Thomas F. Luischer, Zhihong Yang, M. Tschudi, L. V. Segesser, P. Stulz, C. Boulanger, R. Siebenmann, M. Turina, F. Buhler (1990). Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins.. Circulation research, 66 4,
    1088-94 . Link: 10.1161/01.RES.66.4.1088
53. H. Kasuya, B. Weir, D. White, K. Stefansson (1993). Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells.. Journal of neurosurgery, 79 6,
    892-8 . Link: 10.3171/JNS.1993.79.6.0892
54. J. D. da Cunha, G. Rae, S. Ferreira, F. Cunha (2004). Endothelins induce ETB receptor-mediated mechanical hypernociception in rat hindpaw: roles of cAMP and protein kinase C.. European journal of pharmacology, 501 1-3,
    87-94 . Link: 10.1016/J.EJPHAR.2004.08.004
55. T. Murohara, A. M. Lefer (1996). Autocrine effects of endothelin-1 on leukocyte-endothelial interaction: stimulation of endothelin B receptor subtype reduces endothelial adhesiveness via a nitric oxide-dependent mechanism.. Blood, 88 10,
    3894-900 . Link: 10.1182/BLOOD.V88.10.3894.BLOODJOURNAL88103894
56. Bin Fan, S. Dun, J. Gu, Yang Guo, S. Ikuyama (2015). Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-κB and AP-1 Activation. PLoS ONE, 10, . Link: 10.1371/journal.pone.0137837
57. Yasuo Matsumura, K. Hisaki, M. Takaoka, Shiro Morimoto (1990). Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1.. European journal of pharmacology, 185 1,
    103-6 . Link: 10.1016/0014-2999(90)90216-S
58. Stephen A. Douglas, C. Louden, L. Vickery-Clark, B. Storer, Timothy Hart, G. Feuerstein, John D. Elliott, E. Ohlstein (1994). A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670.. Circulation research, 75 1,
    190-7 . Link: 10.1161/01.RES.75.1.190
59. L. Packer, G. Rimbach, F. Virgili (1999). Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol.. Free radical biology & medicine, 27 5-6,
    704-24 . Link: 10.1016/S0891-5849(99)00090-8
60. E. Bayeta, B. Lau (2000). Pycnogenol inhibits generation of inflammatory mediators in macrophages. Nutrition Research, 20, 249-259. Link: 10.1016/S0271-5317(99)00157-8
61. Juhee Ahn, I. Grün, A. Mustapha (2007). Effects of plant extracts on microbial growth, color change, and lipid oxidation in cooked beef.. Food microbiology, 24 1,
    7-14 . Link: 10.1016/J.FM.2006.04.006
62. You Jung Kim, K. Kang, T. Yokozawa (2008). The anti-melanogenic effect of pycnogenol by its anti-oxidative actions.. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 46 7,
    2466-71 . Link: 10.1016/j.fct.2008.04.002
63. O. Lee, Min-Jung Seo, Hyeon‐Son Choi, Boo-Yong Lee (2012). Pycnogenol® Inhibits Lipid Accumulation in 3T3‐L1 Adipocytes with the Modulation of Reactive Oxygen Species (ROS) Production Associated with Antioxidant Enzyme Responses. Phytotherapy Research, 26, . Link: 10.1002/ptr.3568
64. J. Ryan, K. Croft, Trevor A. Mori, K. Wesnes, Joanne Spong, L. Downey, C. Kure, J. Lloyd, C. Stough (2008). An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population. Journal of Psychopharmacology, 22, 553 - 562. Link: 10.1177/0269881108091584
65. Kehkashan Parveen, Mohd Rashid Khan, M. Mujeeb, W. Siddiqui (2010). Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats.. Chemico-biological interactions, 186 2,
    219-27 . Link: 10.1016/j.cbi.2010.04.023
66. Audwin B. Nelson, B. Lau, N. Ide, Y. Rong (1998). Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation, and hydroxyl radical-induced DNA damage.. Drug development and industrial pharmacy, 24 2,
    139-44 . Link: 10.3109/03639049809085598
67. M. Sivonová, I. Žitňanová, L. Horakova, M. Štrosová, J. Muchova, P. Balgavý, D. Dobrota, Z. Ďuračková (2006). The combined effect of pycnogenol with ascorbic acid and trolox on the oxidation of lipids and proteins.. General physiology and biophysics, 25 4,
    379-96 . Link:
68. M. Ansari, J. Keller, S. Scheff (2008). Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity.. Free radical biology & medicine, 45 11,
    1510-9 . Link: 10.1016/j.freeradbiomed.2008.08.025
69. F. Enseleit, I. Sudano, D. Périat, S. Winnik, M. Wolfrum, A. Flammer, G. Fröhlich, P. Kaiser, A. Hirt, S. Haile, Nazmi Krasniqi, C. Matter, Klaus Uhlenhut, P. Högger, M. Neidhart, T. Lüscher, F. Ruschitzka, G. Noll (2012). Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.. European heart journal, 33 13,
    1589-97 . Link: 10.1093/eurheartj/ehr482
70. Ximing Liu, Junping Wei, F. Tan, Shengmin Zhou, G. Würthwein, P. Rohdewald (2004). Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II.. Life sciences, 75 21,
    2505-13 . Link: 10.1016/J.LFS.2003.10.043
71. Kehkashan Parveen, Mohd Rashid Khan, M. Mujeeb, W. Siddiqui (2010). Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats.. Chemico-biological interactions, 186 2,
    219-27 . Link: 10.1016/j.cbi.2010.04.023
72. S. Zibadi, P. Rohdewald, Danna Park, Ronald Ross Watson (2008). Reduction of Cardiovascular Risk Factors in Subjects with Type 2 Diabetes by Pycnogenol® Supplementation. The FASEB Journal, 22, . Link: 10.1016/j.nutres.2008.03.003
73. Mahsa Malekahmadi, Safieh Firouzi, Reza Daryabeygi-Khotbehsara, Sheikh Mohammed Shariful Islam, A. Norouzy, Omid Moradi Moghaddam, Sepideh Soltani (2019). Effects of Pycnogenol on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Pharmacological research, ,
    104472 . Link: 10.1016/j.phrs.2019.104472
74. W. Feng, H. Wei, G. T. Liu (2002). Effect of PYCNOGENOL on the toxicity of heart, bone marrow and immune organs as induced by antitumor drugs.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 9 5,
    414-8 . Link: 10.1078/09447110260571652
75. Kehkashan Parveen, Tauheed Ishrat, S. Malik, M. A. Kausar, W. Siddiqui (2012). Modulatory effects of Pycnogenol® in a rat model of insulin-dependent diabetes mellitus: biochemical, histological, and immunohistochemical evidences. Protoplasma, 250, 347 - 360. Link: 10.1007/s00709-012-0418-2
76. J. Ryan, K. Croft, Trevor A. Mori, K. Wesnes, Joanne Spong, L. Downey, C. Kure, J. Lloyd, C. Stough (2008). An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population. Journal of Psychopharmacology, 22, 553 - 562. Link: 10.1177/0269881108091584
77. L. Packer, G. Rimbach, F. Virgili (1999). Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol.. Free radical biology & medicine, 27 5-6,
    704-24 . Link: 10.1016/S0891-5849(99)00090-8
78. A. Rašković, Nina Bukumirović, M. Paut Kusturica, N. Milić, V. Čabarkapa, I. Borišev, I. Capo, Dejan Miljkovic, N. Stilinović, M. Mikov (2018). Hepatoprotective and antioxidant potential of Pycnogenol® in acetaminophen‐induced hepatotoxicity in rats. Phytotherapy Research, 33, 631 - 639. Link: 10.1002/ptr.6251
79. G. Belcaro, P. Rohdewald, M. Cesarone, C. Scipione, V. Scipione, U. Cornelli, R. Luzzi, R. Cotellese, M. Dugall, M. Hosoi, M. Corsi, B. Feragalli (2022). Restless legs syndrome: prevention with Pycnogenol® and improvement of the venoarteriolar response.. Panminerva medica, 64 2,
    253-258 . Link: 10.23736/S0031-0808.20.04046-X
80. C. Petrassi, A. Mastromarino, C. Spartera (2000). PYCNOGENOL in chronic venous insufficiency.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 7 5,
    383-8 . Link: 10.1016/S0944-7113(00)80059-8
81. O. P. Gulati (2014). Pycnogenol® in Chronic Venous Insufficiency and Related Venous Disorders. Phytotherapy Research, 28, . Link: 10.1002/ptr.5019
82. G. Belcaro, M. Cesarone, B. Errichi, A. Ledda, A. Di Renzo, S. Stuard, M. Dugall, L. Pellegrini, P. Rohdewald, E. Ippolito, A. Ricci, M. Cacchio, I. Ruffini, F. Fano, M. Hosoi (2005). Venous Ulcers: Microcirculatory Improvement and Faster Healing with Local Use of Pycnogenol®. Angiology, 56, 699 - 705. Link: 10.1177/000331970505600607
83. G. Belcaro, U. Cornelli, M. Dugall, M. Hosoi, R. Cotellese, B. Feragalli (2018). Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study).. Minerva cardioangiologica, 66 2,
    152-159 . Link: 10.23736/S0026-4725.17.04577-7
84. O. P. Gulati (2008). PYCNOGENOL: A NUTRACEUTICAL FOR VENOUS HEALTH. Biomedical Reviews, 19, 33-43. Link: 10.14748/BMR.V19.59
85. M. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, E. Ippolito, M. Scoccianti, A. Ricci, M. Dugall, M. Cacchio, I. Ruffini, F. Fano, G. Acerbi, M. G. Vinciguerra, P. Bavera, A. Di Renzo, B. Errichi, F. Mucci (2005). Prevention of Edema in Long Flights with Pycnogenol®. Clinical and Applied Thrombosis/Hemostasis, 11, 289 - 294. Link: 10.1177/107602960501100307
86. Cesarone Mr, G. Belcaro, Peter Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, E. Ippolito, F. Fano, M. Dugall, M. Cacchio, A. Renzo, M. Hosoi, S. Stuard, M. Corsi (2010). Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 17 11,
    835-9 . Link: 10.1016/j.phymed.2010.04.009
87. G. Belcaro, Cesarone Mr, S. Errichi, C. Zulli, B. Errichi, G. Vinciguerra, A. Ledda, A. Renzo, S. Stuard, M. Dugall, L. Pellegrini, G. Gizzi, E. Ippolito, A. Ricci, M. Cacchio, G. Cipollone, I. Ruffini, F. Fano, M. Hosoi, P. Rohdewald (2008). Treatment of osteoarthritis with Pycnogenol®. The SVOS (San Valentino osteo‐arthrosis study). evaluation of signs, symptoms, physical performance and vascular aspects. Phytotherapy Research, 22, . Link: 10.1002/ptr.2376
88. P. Arcangeli (2000). Pycnogenol in chronic venous insufficiency.. Fitoterapia, 71 3,
    236-44 . Link: 10.1016/S0367-326X(99)00164-1
89. B. Ference, H. Ginsberg, I. Graham, K. Ray, C. Packard, E. Bruckert, R. Hegele, R. Krauss, F. Raal, H. Schunkert, G. Watts, J. Borén, S. Fazio, J. Horton, L. Masana, S. Nicholls, B. Nordestgaard, B. Nordestgaard, B. Sluis, M. Taskinen, L. Tokgozoglu, U. Landmesser, U. Landmesser, U. Landmesser, U. Laufs, O. Wiklund, O. Wiklund, Jane K. Stock, M. Chapman, A. Catapano (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal, 38, 2459 - 2472. Link: 10.1093/eurheartj/ehx144
90. I. Jialal, S. M. Grundy (1992). Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein.. Journal of lipid research, 33 6,
    899-906 . Link:
91. Mahsa Malekahmadi, Safieh Firouzi, Reza Daryabeygi-Khotbehsara, Sheikh Mohammed Shariful Islam, A. Norouzy, Omid Moradi Moghaddam, Sepideh Soltani (2019). Effects of Pycnogenol on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Pharmacological research, ,
    104472 . Link: 10.1016/j.phrs.2019.104472
92. P. Toth, N. Sattar, D. Blom, S. Martin, S. Jones, M. Monsalvo, M. Elliott, Michael T. Davis, R. Somaratne, D. Preiss (2018). Effect of Evolocumab on Lipoprotein Particles.. The American journal of cardiology, 121 3,
    308-314 . Link: 10.1016/j.amjcard.2017.10.028
93. R. Liu, Bin Fan, Huiying Cong, S. Ikuyama, H. Guan, J. Gu (2016). Pycnogenol Reduces Toll-Like Receptor 4 Signaling Pathway-Mediated Atherosclerosis Formation in Apolipoprotein E-Deficient Mice. Journal of Cardiovascular Pharmacology, 68, 292–303. Link: 10.1097/FJC.0000000000000415
94. Audwin B. Nelson, B. Lau, N. Ide, Y. Rong (1998). Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation, and hydroxyl radical-induced DNA damage.. Drug development and industrial pharmacy, 24 2,
    139-44 . Link: 10.3109/03639049809085598
95. S. Zibadi, P. Rohdewald, Danna Park, Ronald Ross Watson (2008). Reduction of Cardiovascular Risk Factors in Subjects with Type 2 Diabetes by Pycnogenol® Supplementation. The FASEB Journal, 22, . Link: 10.1016/j.nutres.2008.03.003
96. Dr.Amar Maola Hmod, Rasha Zuhair (2019). Study the action of pycnogenol on glucose and lipid profile in type -2- diabetic patients. journal of the college of basic education, , . Link: 10.35950/CBEJ.V17I72.4496
97. A. Sahebkar (2014). A Systematic Review and Meta-Analysis of the Effects of Pycnogenol on Plasma Lipids. Journal of Cardiovascular Pharmacology and Therapeutics, 19, 244 - 255. Link: 10.1177/1074248413511691
98. A. Hadi, M. Pourmasoumi, H. Mohammadi, Aftab Javaheri, M. Rouhani (2018). The impact of pycnogenol supplementation on plasma lipids in humans: A systematic review and meta‐analysis of clinical trials. Phytotherapy Research, 33, 276 - 287. Link: 10.1002/ptr.6234
99. Xiaoqian Liu, G. Machado, J. Eyles, V. Ravi, D. Hunter (2017). Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. British Journal of Sports Medicine, 52, 167 - 175. Link: 10.1136/bjsports-2016-097333
100. Mateja Sirše, S. Fokter, B. Strukelj, J. Zupan (2020). Silver Fir (Abies alba L.) Polyphenolic Extract Shows Beneficial Influence on Chondrogenesis In Vitro under Normal and Inflammatory Conditions. Molecules, 25, . Link: 10.3390/molecules25204616
101. G. Belcaro, Cesarone Mr, S. Errichi, C. Zulli, B. Errichi, G. Vinciguerra, A. Ledda, A. Renzo, S. Stuard, M. Dugall, L. Pellegrini, G. Gizzi, E. Ippolito, A. Ricci, M. Cacchio, G. Cipollone, I. Ruffini, F. Fano, M. Hosoi, P. Rohdewald (2008). Treatment of osteoarthritis with Pycnogenol®. The SVOS (San Valentino osteo‐arthrosis study). evaluation of signs, symptoms, physical performance and vascular aspects. Phytotherapy Research, 22, . Link: 10.1002/ptr.2376
102. R. Farid, Z. Mirfeizi, Mahyar Mirheidari, Z. Rezaieyazdi, H. Mansouri, Habib Esmaelli, S. Zibadi, P. Rohdewald, R. Watson (2007). Pycnogenol supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis. Nutrition Research, 27, 692-697. Link: 10.1016/J.NUTRES.2007.09.007
103. Peter Jörg Rohdewald (2017). Review on Sustained Relief of Osteoarthritis Symptoms with a Proprietary Extract from Pine Bark, Pycnogenol. Journal of Medicinal Food, 21, 1 - 4. Link: 10.1089/jmf.2017.0015
104. A. Schoonees, J. Visser, A. Musekiwa, J. Volmink (2012). Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders.. The Cochrane database of systematic reviews, 4,
     CD008294 . Link: 10.1002/14651858.CD008294.pub4
105. S. Jessberger, P. Högger, F. Genest, D. Salter, L. Seefried (2017). Cellular pharmacodynamic effects of Pycnogenol® in patients with severe osteoarthritis: a randomized controlled pilot study. BMC Complementary and Alternative Medicine, 17, . Link: 10.1186/s12906-017-2044-1
106. B. Feragalli, M. Dugall, R. Luzzi, A. Ledda, M. Hosoi, G. Belcaro, M. Cesarone (2018). Pycnogenol®: supplementary management of symptomatic osteoarthritis with a patch. An observational registry study.. Minerva endocrinologica, 44 1,
     97-101 . Link: 10.23736/S0391-1977.18.02820-1
107. G. Belcaro, Cesarone Mr, S. Errichi, C. Zulli, B. Errichi, G. Vinciguerra, A. Ledda, A. Renzo, S. Stuard, M. Dugall, L. Pellegrini, G. Gizzi, E. Ippolito, A. Ricci, M. Cacchio, G. Cipollone, I. Ruffini, F. Fano, M. Hosoi, P. Rohdewald (2008). Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol®. Redox Report, 13, 271 - 276. Link: 10.1179/135100008X309019
108. Melanie Mülek, L. Seefried, F. Genest, P. Högger (2017). Distribution of Constituents and Metabolites of Maritime Pine Bark Extract (Pycnogenol®) into Serum, Blood Cells, and Synovial Fluid of Patients with Severe Osteoarthritis: A Randomized Controlled Trial. Nutrients, 9, . Link: 10.3390/nu9050443